ArticleThe Pan African medical journal2025
Long COVID symptoms in the COVID unit of the emergency Department of Abderrahmen Mami Hospital in Tunisia: prevalence, main symptoms, and associated factors.
Article in The Pan African medical journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: the COVID-19 pandemic has been evolving since 2019, affecting over 536 million individuals and causing more than six million deaths. After the acute phase, the onset or persistence of symptoms grouped under the name of long COVID is reported. The variability of symptomatology makes this a relevant subject of study, since more than one million cases of COVID-19 have been reported in Tunisia. The aim of our study was to determine the prevalence and potential risk factors for long COVID. Methods: we conducted a retrospective cohort study of patients admitted to the COVID unit of the emergency department of Abderrahmane Mami Hospital in Tunisia from April 1st to August 1st, 2021. The National Institute of Health Care definition of long COVID (November 2021) was adopted. Results: overall, 1,271 patients were admitted during the study period. After excluding deceased and unreachable patients by telephone, 454 were included in the analysis. The mean age was 58.6 ± 13.9 years, with a male predominance (53.7%). The prevalence of long COVID was 84.8%. The most common manifestations were breathing discomfort, asthenia, memory problems, tiredness, and arthralgia. In multivariable analysis, female sex was identified as a risk factor for long COVID (aOR: 1.732, 95% CI 1.002-2.995; p = 0.049). Conclusion: the high prevalence of long COVID observed in our study highlights the need for post-COVID follow-up among affected patients. Our findings suggest that women had a higher risk of developing long COVID, indicating the benefit of individualized monitoring and care programs for this group.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.